W

WuXi XDC Cayman Inc
HKEX:2268

Watchlist Manager
WuXi XDC Cayman Inc
HKEX:2268
Watchlist
Price: 26.15 HKD -1.88%
Market Cap: 31.4B HKD
Have any thoughts about
WuXi XDC Cayman Inc?
Write Note

WuXi XDC Cayman Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

WuXi XDC Cayman Inc
Cost of Revenue Peer Comparison

Comparables:
603259
300759
2269
300347
M
688114

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
W
WuXi XDC Cayman Inc
HKEX:2268
Cost of Revenue
-ÂĄ1.6B
CAGR 3-Years
-161%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Cost of Revenue
-ÂĄ23.3B
CAGR 3-Years
-23%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Cost of Revenue
-ÂĄ7.7B
CAGR 3-Years
-25%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Cost of Revenue
-ÂĄ10.5B
CAGR 3-Years
-38%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Cost of Revenue
-ÂĄ4.4B
CAGR 3-Years
-29%
CAGR 5-Years
-24%
CAGR 10-Years
-35%
M
MGI Tech Co Ltd
SSE:688114
Cost of Revenue
-ÂĄ1.4B
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is WuXi XDC Cayman Inc's Cost of Revenue?
Cost of Revenue
-1.6B CNY

Based on the financial report for Dec 31, 2023, WuXi XDC Cayman Inc's Cost of Revenue amounts to -1.6B CNY.

What is WuXi XDC Cayman Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-161%

Over the last year, the Cost of Revenue growth was -114%. The average annual Cost of Revenue growth rates for WuXi XDC Cayman Inc have been -161% over the past three years .

Back to Top